Chapter 21. Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy

  1. Barry J. Maron MD
  1. Asifa Quraishi MB, MRCP,
  2. Mohammad S. Hamid MB, MRCP and
  3. William J. Mckenna MD, FRCP

Published Online: 25 OCT 2007

DOI: 10.1002/9780470987469.ch21

Diagnosis and Management of Hypertrophic Cardiomyopathy

Diagnosis and Management of Hypertrophic Cardiomyopathy

How to Cite

Quraishi, A., Hamid, M. S. and Mckenna, W. J. (2007) Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy, in Diagnosis and Management of Hypertrophic Cardiomyopathy (ed B. J. Maron), Blackwell Publishing, Malden, Massachusetts, USA. doi: 10.1002/9780470987469.ch21

Editor Information

  1. Director, The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota

Publication History

  1. Published Online: 25 OCT 2007
  2. Published Print: 27 FEB 2004

ISBN Information

Print ISBN: 9781405117326

Online ISBN: 9780470987469

SEARCH

Keywords:

  • atrioventricular block;
  • supraventricular arrhythmia;
  • myocardial ischemia;
  • hemodynamic alterations;
  • implantable cardioverter defibrillators

Summary

This chapter contains sections titled:

  • Role of risk stratification for sudden death in HCM

  • Molecular tools for risk stratification

  • Clinical tools for risk stratification

  • Other risk factors

  • Development of an individual patient's risk factor profile

  • Recommendations